- Home
- WIW vs UPB Comparison
WIW vs UPB Comparison
Compare WIW & UPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIW
- UPB
- Stock Information
- Founded
- WIW 2004
- UPB 2021
- Country
- WIW United States
- UPB United States
- Employees
- WIW N/A
- UPB N/A
- Industry
- WIW Finance Companies
- UPB
- Sector
- WIW Finance
- UPB
- Exchange
- WIW Nasdaq
- UPB NYSE
- Market Cap
- WIW 522.5M
- UPB 622.8M
- IPO Year
- WIW N/A
- UPB 2024
- Fundamental
- Price
- WIW $8.55
- UPB $11.00
- Analyst Decision
- WIW
- UPB Strong Buy
- Analyst Count
- WIW 0
- UPB 4
- Target Price
- WIW N/A
- UPB $56.50
- AVG Volume (30 Days)
- WIW 229.9K
- UPB 442.0K
- Earning Date
- WIW 01-01-0001
- UPB 02-14-2025
- Dividend Yield
- WIW 11.14%
- UPB N/A
- EPS Growth
- WIW N/A
- UPB N/A
- EPS
- WIW N/A
- UPB N/A
- Revenue
- WIW N/A
- UPB $2,207,000.00
- Revenue This Year
- WIW N/A
- UPB N/A
- Revenue Next Year
- WIW N/A
- UPB N/A
- P/E Ratio
- WIW N/A
- UPB N/A
- Revenue Growth
- WIW N/A
- UPB 82.10
- 52 Week Low
- WIW $8.01
- UPB $10.36
- 52 Week High
- WIW $9.37
- UPB $29.46
- Technical
- Relative Strength Index (RSI)
- WIW 63.98
- UPB N/A
- Support Level
- WIW $8.23
- UPB N/A
- Resistance Level
- WIW $8.60
- UPB N/A
- Average True Range (ATR)
- WIW 0.06
- UPB 0.00
- MACD
- WIW 0.04
- UPB 0.00
- Stochastic Oscillator
- WIW 85.90
- UPB 0.00
About WIW Western Asset Inflation-Linked Opportunities & Income Fund
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. Its primary investment objective of the group is to provide current income for its shareholders. The secondary investment objective is capital appreciation with current income.
About UPB UPSTREAM BIO INC
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases.